|
|
| 47.44 Data as of Apr 17 |  +0.95 / +2.04%Today’s Change | 41.52 Today|||52-Week Range 57.34 | +0.76% Year-to-Date |
| Previous close | 46.49 |
| Today’s open | 46.93 |
| Day’s range | 46.47 - 47.49 |
| Volume | 1,415,249 |
| Average volume (3 months) | 1,174,123 |
| Market cap | $6.4B |
| Dividend yield | 2.11% |
| Earnings growth (last year) | +22.81% |
| Earnings growth (this year) | +9.98% |
| Earnings growth (next 5 years) | +12.00% |
| Revenue growth (last year) | +10.66% |
| P/E ratio | 21.3 |
| Price/Sales | 4.26 |
| Price/Book | 3.99 |
| Today’s change | Today’s % change | |
|---|---|---|
| VARVarian Medical Syste... | -0.61 | -0.75% |
| TFXTeleflex Inc | -0.34 | -0.33% |
| PCRXPacira Pharmaceutica... | -1.67 | -2.47% |
| THORThoratec Corp | -0.32 | -0.94% |
| Next reporting date | April 24, 2014 |
| EPS forecast (this quarter) | $0.64 |
| Annual revenue (last year) | $1.5B |
| Annual profit (last year) | $307.1M |
| Net profit margin | 20.28% |
Sector Health Technology |
Industry Medical Specialties |
Chief Executive Officer & Director Michael J. Farrell |
President & Chief Operating Officer Robert Andrew Douglas |
Corporate headquarters San Diego, California |
.
